PACT & Health

PACT & Health is a biotechnology company specializing in radiation oncology and translational cancer research. The company focuses on developing radiation-modifying agents, including radiosensitizers and radioprotectants, to enhance the efficacy of cancer treatments while minimizing toxicity. Their core technology is the I-PARTS platform, an integrated system for high-throughput screening of anti-cancer radiation therapeutics. PACT & Health also explores nanomedicine applications, such as radiation-activated photodynamic therapy, and utilizes AI-driven workflows for preclinical oncology. The company is supported by significant funding from the National Cancer Institute (NCI) through SBIR contracts and maintains collaborations with institutions like NASA-Ames and the University of Kansas Medical Center.